blue | bleu

Brain Tumour

The Brain Tumour Program at the Montreal Neurological Institute and Hospital is one of the largest and most comprehensive brain tumour research and treatment programs in the country. It includes the Brain Tumour Research Centre, the Translational Neuro-Oncology Program and the interdisciplinary Clinical Neuro-Oncology Program.

Areas of research include, but are not limited to, uncovering fundamental regulatory mechanisms that govern brain cancer development, regulate brain cancer stem-cell self-renewal and differentiation, drive invasion, and lead to treatment resistance.  All state-of-the-art technologies are available including next-generation genomic and epigenomic testing, computational biology approaches, cell-based assays for drug screening, patient-derived cranial xenograft modeling, and small animal imaging.

The Brain Tumour Research Centre is directly integrated with The Neuro, enabling interactions and collaborations with molecular, cellular, and developmental neuroscientists and research groups.

Integration with the translational and clinical neuro-oncology programs ensures the seamless transition of discoveries into novel therapeutics clinical trial testing.

Group Leader
Kevin Petrecca

Primary Group Members

Marie-Christine Guiot
Richard Leblanc
Kevin Petrecca
Stefano Stifani, Associate Group Leader
Donatella Tampieri
Roberto J. Diaz

Affiliated Group Members

Peter McPherson
Josephine Nalbantoglu



The Montreal Neurological Institute & Hospital is a McGill University research and teaching institute; delivering the highest quality of care to patients, as part of the Neuroscience Mission of the McGill University Health Centre. The Neuro is proud to be a Killam Institution, supported by the Killam Trusts.